GB1230663A
(da)
|
1968-12-10 |
1971-05-05 |
|
|
GB1356789A
(en)
|
1970-08-06 |
1974-06-12 |
Prodotti Antibiotici Spa |
Derivatives of theophylline
|
DE2050657C3
(de)
|
1970-10-15 |
1974-06-20 |
Basf Ag, 6700 Ludwigshafen |
Azofarbstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
|
US3970753A
(en)
|
1973-06-12 |
1976-07-20 |
Smith Kline & French Laboratories Limited |
Imidazo[1,2-a]pyridines
|
DE2361390A1
(de)
|
1973-12-10 |
1975-06-19 |
Merck Patent Gmbh |
Isochinolinderivate und verfahren zu ihrer herstellung
|
DE2832677A1
(de)
|
1978-07-26 |
1980-02-07 |
Bayer Ag |
Hydroxypropyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
US4246274A
(en)
|
1978-05-10 |
1981-01-20 |
Bayer Aktiengesellschaft |
Antimycotic hydroxypropyl-imidazoles
|
DE3210570A1
(de)
|
1982-03-23 |
1983-10-06 |
Hoechst Ag |
3-azolyl-1,2-diaryl-1-halogen-1-propene, ihre herstellung, ihre verwendung als pflanzenschutzmittel und diese verbindungen enthaltende praeparate
|
WO1984002907A1
(en)
|
1983-01-21 |
1984-08-02 |
Alkaloida Vegyeszeti Gyar |
New alkyl diamine derivatives
|
ATE124999T1
(de)
|
1985-03-15 |
1995-07-15 |
Antivirals Inc |
Immunotestmittel für polynukleotid und verfahren.
|
DE3628545A1
(de)
|
1985-09-23 |
1987-04-23 |
Hoechst Ag |
Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
JPH07100688B2
(ja)
|
1986-02-12 |
1995-11-01 |
大日本製薬株式会社 |
環状アミン誘導体
|
JPH07121911B2
(ja)
|
1986-03-26 |
1995-12-25 |
クミアイ化学工業株式会社 |
4(1h)−ピリジノン誘導体および農園芸用殺菌剤
|
DE3631013A1
(de)
|
1986-09-12 |
1988-03-24 |
Thomae Gmbh Dr K |
Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
EP0301751B1
(en)
|
1987-07-31 |
1993-03-10 |
Takeda Chemical Industries, Ltd. |
Pyridinium derivatives, their production and use
|
US5210266A
(en)
|
1987-12-03 |
1993-05-11 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
US5179125A
(en)
|
1987-12-03 |
1993-01-12 |
Dainippon Pharmaceutical Co., Ltd. |
N-substituted mercaptopropanamide derivatives
|
GB8820231D0
(en)
*
|
1988-08-25 |
1988-09-28 |
Fujisawa Pharmaceutical Co |
New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
|
FR2638747B1
(fr)
|
1988-11-08 |
1993-12-24 |
Synthelabo |
Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
|
DE3901723A1
(de)
|
1989-01-21 |
1990-07-26 |
Bayer Ag |
Azolyl-derivate
|
JP2769711B2
(ja)
|
1989-02-17 |
1998-06-25 |
昭和電工株式会社 |
オレフィン重合用触媒成分の製造方法及びオレフィンの重合方法
|
AU6143790A
(en)
|
1989-07-04 |
1991-01-17 |
Kumpf, Ursula |
Process and device for drawing optical fibre cables into protective pipes
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
US5229516A
(en)
|
1989-10-27 |
1993-07-20 |
American Home Products Corporation |
Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
|
US5420289A
(en)
|
1989-10-27 |
1995-05-30 |
American Home Products Corporation |
Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
|
ES2069137T3
(es)
|
1990-07-30 |
1995-05-01 |
Takeda Chemical Industries Ltd |
Derivados de imidazopiridina y su uso.
|
EP0547231B1
(en)
|
1991-07-03 |
1996-08-28 |
Shionogi & Co., Ltd. |
Phospholipase a2 inhibitor
|
EP0533056A3
(en)
|
1991-09-14 |
1993-06-16 |
Hoechst Aktiengesellschaft |
Substituted aminopropanes, process for their preparation and their use as antimycotic agents
|
US5273980A
(en)
|
1991-09-30 |
1993-12-28 |
Merck Frosst Canada Inc. |
Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
|
CA2079374C
(en)
|
1991-09-30 |
2003-08-05 |
Merck Frosst Canada Incorporated |
(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
US5330989A
(en)
|
1991-10-24 |
1994-07-19 |
American Home Products Corporation |
Heterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivatives
|
WO1993012094A1
(de)
|
1991-12-10 |
1993-06-24 |
Hoechst Schering Agrevo Gmbh |
Pyrimidinyl- oder triazinyl-oxy-(oder -thio)-aldehydderivate, und verwendung als herbizide oder pflanzenwachstumsregulatoren
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
DE4227522A1
(de)
|
1992-08-20 |
1994-02-24 |
Bayer Ag |
Lichtpolarisierende Folien und neue dichroitische Farbstoffe hierfür
|
JP3298954B2
(ja)
|
1992-12-16 |
2002-07-08 |
三共株式会社 |
新規n,n’−ジベンゾイルヒドラジン誘導体及び殺虫組成物
|
US5484926A
(en)
|
1993-10-07 |
1996-01-16 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
ES2159798T3
(es)
|
1993-03-29 |
2001-10-16 |
Astrazeneca Ab |
Derivados heterociclicos como inhibidores de la agregacion plaquetaria.
|
IL109220A0
(en)
|
1993-04-05 |
1994-07-31 |
Synaptic Pharma Corp |
Dihydropyridines and new uses thereof
|
EP0700389A1
(en)
|
1993-05-27 |
1996-03-13 |
Smithkline Beecham Laboratoires Pharmaceutiques |
Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
|
FR2706895A1
(en)
|
1993-06-22 |
1994-12-30 |
Synthelabo |
Tetrahydroisoquinoline derivatives, their preparation and their application in therapeutics
|
JPH07179402A
(ja)
|
1993-10-20 |
1995-07-18 |
Ishihara Sangyo Kaisha Ltd |
置換ベンゼン誘導体、その製造方法及びそれを含有する有害生物防除剤
|
US5461154A
(en)
|
1994-02-02 |
1995-10-24 |
Eli Lilly And Company |
Intermediate and process for making
|
TW281667B
(da)
|
1994-02-03 |
1996-07-21 |
Synthelabo |
|
GB9402807D0
(en)
|
1994-02-14 |
1994-04-06 |
Xenova Ltd |
Pharmaceutical compounds
|
JPH07304770A
(ja)
|
1994-05-11 |
1995-11-21 |
Kanebo Ltd |
新規ベンゾアゼピノン誘導体
|
US5593994A
(en)
|
1994-09-29 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Prostaglandin synthase inhibitors
|
EP0793653A1
(en)
|
1994-11-23 |
1997-09-10 |
Neurogen Corporation |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
|
US5541033A
(en)
|
1995-02-01 |
1996-07-30 |
Ocg Microelectronic Materials, Inc. |
Selected o-quinonediazide sulfonic acid esters of phenolic compounds and their use in radiation-sensitive compositions
|
US20030018025A1
(en)
|
1995-06-07 |
2003-01-23 |
Neurogen Corporation, Corporation Of The State Of Delaware |
Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives: new classes of dopamine receptor subtype specific ligands
|
US5554621A
(en)
|
1995-06-07 |
1996-09-10 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
|
WO1997009066A1
(fr)
|
1995-09-08 |
1997-03-13 |
Kanebo, Ltd. |
INHIBITEUR DE SOLUBILISATION DE LIGAND Fas
|
KR19990076878A
(ko)
|
1995-12-29 |
1999-10-25 |
스티븐 베네티아너 |
비트로넥틴 수용체 길항제
|
CA2251625A1
(en)
|
1996-04-24 |
1997-10-30 |
Yumiko Shibouta |
Fused imidazopyridine derivatives as antihyperlipidemic agents
|
EP0819977B1
(en)
|
1996-07-17 |
2006-01-04 |
Fuji Photo Film Co., Ltd. |
Oxonol compound and silver halide photographic material
|
GB9717576D0
(en)
|
1997-08-19 |
1997-10-22 |
Xenova Ltd |
Pharmaceutical compounds
|
HN1997000027A
(es)
|
1996-12-06 |
1997-06-05 |
Pfizer Prod Inc |
Derivados de 6-fenil piridil - 2 amina
|
HUP9700392A1
(hu)
|
1997-02-10 |
1999-09-28 |
ICN Magyarország Részvénytársaság |
Egy vagy két hatóanyagot tartalmazó kardioprotektív hatású gyógyszerkészítmények
|
US6048877A
(en)
|
1997-02-21 |
2000-04-11 |
Bristol-Myers Squibb Company |
Tetralone derivatives as antiarrhythmic agents
|
US6310107B1
(en)
|
1997-02-27 |
2001-10-30 |
Takeda Chemical Industries, Ltd. |
Amine compounds, their production and use as amyloid-β production inhibitors
|
DE19717371A1
(de)
|
1997-04-24 |
1998-10-29 |
Basf Ag |
Propargyl-terminierte, nematische oder cholesterische Polymere
|
PL338614A1
(en)
|
1997-07-31 |
2000-11-06 |
Hoffmann La Roche |
O-substituted derivatives of hydroxyenmarone as anticarcinogenic and antinetastic agents
|
JPH11119379A
(ja)
|
1997-10-08 |
1999-04-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料および画像形成方法
|
WO1999032447A2
(en)
|
1997-12-11 |
1999-07-01 |
American Home Products Corporation |
2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
|
TW555757B
(en)
|
1998-07-31 |
2003-10-01 |
Akzo Nobel Nv |
Aminomethylcarboxylic acid derivatives
|
DE19834751A1
(de)
|
1998-08-01 |
2000-02-03 |
Boehringer Ingelheim Pharma |
Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel
|
AU6124699A
(en)
|
1998-10-20 |
2000-05-08 |
Takeda Chemical Industries Ltd. |
Aromatic amine derivatives, process for the preparation thereof and agents containing the same
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
US6357758B1
(en)
|
1999-06-30 |
2002-03-19 |
Federal-Mogul World Wide, Inc. |
Metal gasket and method of manufacturing
|
JP4603679B2
(ja)
|
1999-12-14 |
2010-12-22 |
日本化薬株式会社 |
害虫防除剤
|
GB0007108D0
(en)
|
2000-03-23 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
US6534651B2
(en)
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
CA2407088A1
(en)
|
2000-05-19 |
2001-11-22 |
Takeda Chemical Industries, Ltd. |
Beta-secretase inhibitors
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
AU2001273094A1
(en)
|
2000-06-30 |
2002-01-14 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
US20020094989A1
(en)
|
2000-10-11 |
2002-07-18 |
Hale Jeffrey J. |
Pyrrolidine modulators of CCR5 chemokine receptor activity
|
JP2004512323A
(ja)
|
2000-10-11 |
2004-04-22 |
メルク エンド カムパニー インコーポレーテッド |
Ccr5ケモカイン受容体活性のピロリジンモジュレーター
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
FR2822153B1
(fr)
|
2001-03-19 |
2003-10-31 |
Servier Lab |
Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
DE60205234T2
(de)
|
2001-03-27 |
2006-05-24 |
Actelion Pharmaceuticals Ltd. |
1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
|
FR2822827B1
(fr)
|
2001-03-28 |
2003-05-16 |
Sanofi Synthelabo |
Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
|
CA2443868C
(en)
|
2001-04-10 |
2011-01-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
|
WO2002088089A1
(fr)
|
2001-04-19 |
2002-11-07 |
Banyu Pharmaceutical Co., Ltd. |
Derives de spiropiperidine, antagonistes du recepteur de nociceptine les contenant en tant qu'ingredient actif et compositions medicinales
|
US6720321B2
(en)
|
2001-06-05 |
2004-04-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzo-fused cycloalkyl urea compounds
|
IL158873A0
(en)
|
2001-06-07 |
2004-05-12 |
Lilly Co Eli |
Modulators of peroxisome proliferator activated receptors
|
EP1429776A2
(en)
|
2001-09-21 |
2004-06-23 |
PHARMACIA & UPJOHN COMPANY |
Tricyclic indole derivatives as 5-ht ligands
|
EP1441734B1
(en)
|
2001-10-26 |
2007-02-28 |
Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. |
Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
DE60204718T2
(de)
|
2001-11-20 |
2006-05-18 |
Eli Lilly And Co., Indianapolis |
3-substituierte oxindol beta 3 agonisten
|
DE60225174T2
(de)
|
2001-11-20 |
2009-02-12 |
Eli Lilly And Co., Indianapolis |
Beta-3 adrenergische agonisten
|
GB0202873D0
(en)
|
2002-02-07 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
CA2476681A1
(en)
|
2002-02-19 |
2003-08-28 |
Bruce N. Rogers |
Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
|
US6875780B2
(en)
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
JPWO2004011430A1
(ja)
|
2002-07-25 |
2005-11-24 |
アステラス製薬株式会社 |
ナトリウムチャネル阻害剤
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
AU2003268512A1
(en)
|
2002-09-09 |
2004-03-29 |
Janssen Pharmaceutica N.V. |
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
|
AU2003271185A1
(en)
|
2002-10-15 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Imidazopyridine derivative, process for producing the same, and use
|
AU2003284596A1
(en)
|
2002-11-22 |
2004-06-18 |
Takeda Pharmaceutical Company Limited |
Imidazole derivative, process for producing the same, and use
|
CA2508618C
(en)
|
2002-12-06 |
2012-02-21 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene derivatives
|
CA2511178A1
(en)
|
2002-12-20 |
2004-07-15 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
WO2004078731A1
(fr)
|
2003-03-06 |
2004-09-16 |
'chemical Diversity Research Institute', Ltd. |
Acides quinoline-carboxyliques et leurs derives et bibliotheque focalisee
|
JP4317875B2
(ja)
|
2003-03-11 |
2009-08-19 |
フジフィルム・エレクトロニック・マテリアルズ・ユーエスエイ・インコーポレイテッド |
新規な感光性樹脂組成物
|
JP4226395B2
(ja)
|
2003-06-16 |
2009-02-18 |
アルパイン株式会社 |
音声補正装置
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2005058823A1
(ja)
|
2003-12-17 |
2005-06-30 |
Takeda Pharmaceutical Company Limited |
ウレア誘導体、その製造法及び用途
|
US20050159334A1
(en)
|
2004-01-16 |
2005-07-21 |
Gluck Oscar S. |
Method for treating rheumatoid arthritis by inhibiting peptidylarginine deiminase
|
EP1735319B1
(en)
|
2004-03-26 |
2017-05-03 |
MethylGene Inc. |
Inhibitors of histone deacetylase
|
TWI351282B
(en)
|
2004-04-07 |
2011-11-01 |
Theravance Inc |
Quinolinone-carboxamide compounds as 5-ht4 recepto
|
RU2266906C1
(ru)
|
2004-04-29 |
2005-12-27 |
Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") |
Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
RU2404179C2
(ru)
|
2004-12-22 |
2010-11-20 |
Тереванс, Инк. |
Индазол-карбоксамидные соединения
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
DE102005016547A1
(de)
|
2005-04-08 |
2006-10-12 |
Grünenthal GmbH |
Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
AR054363A1
(es)
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
CN100585892C
(zh)
|
2005-05-25 |
2010-01-27 |
皇家飞利浦电子股份有限公司 |
电致发光器件
|
CA2620476A1
(en)
|
2005-06-02 |
2006-12-07 |
Jenrin Discovery |
Mao-b inhibitors useful for treating obesity
|
ES2359673T3
(es)
|
2005-06-07 |
2011-05-25 |
Theravance, Inc. |
Compuestos de benzoimidazolona-carboxamida como agonista del receptor 5-ht4.
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
WO2007073505A2
(en)
|
2005-12-22 |
2007-06-28 |
Hydra Biosciences, Inc. |
Trpa1 inhibitors for treating pain
|
CA2636112A1
(en)
|
2006-01-17 |
2007-07-26 |
F.Hoffmann-La Roche Ag |
Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives useful for the treatment of alzheimer's disease via gaba receptors
|
WO2007087548A2
(en)
|
2006-01-25 |
2007-08-02 |
Smithkline Beecham Corporation |
Chemical compounds
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
RU2302417C1
(ru)
|
2006-03-14 |
2007-07-10 |
Иващенко Андрей Александрович |
1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
|
WO2007106469A2
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
CA2540218A1
(en)
|
2006-03-17 |
2007-09-17 |
Hafedh Trigui |
Asymmetric beams for spectrum efficiency
|
DE102006015449A1
(de)
|
2006-03-31 |
2007-10-04 |
Eads Deutschland Gmbh |
Selbstleuchtender Körper und Verfahren zu seiner Herstellung
|
RU2303597C1
(ru)
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008000408A1
(en)
|
2006-06-28 |
2008-01-03 |
Sanofi-Aventis |
Cxcr2 antagonists
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
DE102006039003A1
(de)
|
2006-08-19 |
2008-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Verbindungen
|
US7678792B2
(en)
|
2006-10-20 |
2010-03-16 |
Irm Llc |
Compositions and methods for modulating c-kit and PDGFR receptors
|
JP2010510250A
(ja)
|
2006-11-21 |
2010-04-02 |
ユニバーシティ オブ バージニア パテント ファンデーション |
スフィンゴシン=1−燐酸受容体アゴニスト活性を有するヒドリンダンアナログ
|
ZA200904477B
(en)
|
2006-11-27 |
2010-09-29 |
Lundbeck & Co As H |
Heteroaryl amide derivatives
|
WO2008065500A2
(en)
|
2006-11-30 |
2008-06-05 |
Pfizer Products Inc. |
Heteroaryl amides as type i glycine transport inhibitors
|
EP2125755A2
(en)
|
2006-12-22 |
2009-12-02 |
Novartis Ag |
Quinazolines for pdk1 inhibition
|
EP2137158A4
(en)
|
2007-02-28 |
2012-04-18 |
Methylgene Inc |
LOW-MOLECULAR INHIBITORS OF PROTEINARGININE METHYLTRANSFERASES (PRMTS)
|
CN101686952A
(zh)
|
2007-03-12 |
2010-03-31 |
Vm生物医药公司 |
新型钙离子通道调节剂
|
US20100144751A1
(en)
|
2007-03-28 |
2010-06-10 |
Array Biopharma Inc. |
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
|
JP5313881B2
(ja)
|
2007-04-04 |
2013-10-09 |
興和株式会社 |
テトラヒドロイソキノリン化合物
|
JP2008280344A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物及びそれを含有する有害節足動物防除剤
|
AR066379A1
(es)
|
2007-05-02 |
2009-08-12 |
Boehringer Ingelheim Int |
Amidas de acido carboxilico su preparacion y su uso como medicamentos
|
CA2692004C
(en)
|
2007-06-15 |
2013-04-09 |
Board Of Regents, The University Of Texas System |
Methods and compositions to inhibit edema factor and adenylyl cyclase
|
KR101251933B1
(ko)
|
2007-06-20 |
2013-04-09 |
미쓰비시 타나베 파마 코퍼레이션 |
신규한 말론산술폰아미드 유도체 및 그 의약 용도
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
EA201000201A1
(ru)
|
2007-08-10 |
2010-12-30 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Азотсодержащие бициклические химические вещества для лечения вирусных инфекций
|
WO2009048152A2
(en)
|
2007-10-11 |
2009-04-16 |
Sumitomo Chemical Company, Limited |
Unsaturated imine compound and use thereof for pest control
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
AU2008317473B2
(en)
|
2007-10-19 |
2014-07-17 |
Bausch + Lomb Ireland Limited |
Compositions and methods for treatment of diabetic retinopathy
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
EP2072050A1
(en)
|
2007-12-21 |
2009-06-24 |
Santhera Pharmaceuticals (Schweiz) AG |
Compounds with anti-emetic effect
|
FR2925902B1
(fr)
|
2008-01-02 |
2011-01-07 |
Sanofi Aventis |
DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
RU2371444C1
(ru)
|
2008-01-24 |
2009-10-27 |
Андрей Александрович Иващенко |
ФУРО- И ТИЕНО[2,3-b]-ХИНОЛИН-2-КАРБОКСАМИДЫ, СПОСОБ ПОЛУЧЕНИЯ И ПРОТИВОТУБЕРКУЛЕЗНАЯ АКТИВНОСТЬ
|
EP2254873B1
(en)
|
2008-02-22 |
2014-06-04 |
Otsuka Pharmaceutical Co., Ltd. |
Benzodiazepine compound and pharmaceutical composition
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
WO2009137309A2
(en)
|
2008-05-01 |
2009-11-12 |
Travel Tech Systems, Llc |
Process and system to determine commercial airline arrivals
|
US8148408B2
(en)
|
2008-05-09 |
2012-04-03 |
Abbott Laboratories |
Selective substituted pyridine ligands for neuronal nicotinic receptors
|
WO2009140101A2
(en)
|
2008-05-12 |
2009-11-19 |
Boehringer Ingelheim International Gmbh |
Imidazopyridine compounds useful as mmp-13 inhibitors
|
JP2009274984A
(ja)
|
2008-05-14 |
2009-11-26 |
Sumitomo Chemical Co Ltd |
化合物、光学フィルムおよび光学フィルムの製造方法
|
US20100121052A1
(en)
|
2008-06-20 |
2010-05-13 |
Rama Jain |
Novel compounds for treating proliferative diseases
|
WO2010048207A2
(en)
|
2008-10-21 |
2010-04-29 |
Metabolex, Inc. |
Aryl gpr120 receptor agonists and uses thereof
|
DE102008060958A1
(de)
|
2008-12-06 |
2010-07-08 |
Saltigo Gmbh |
Hydroxytetralone
|
CN102292338B
(zh)
|
2008-12-08 |
2016-09-28 |
萌蒂制药国际有限公司 |
酪氨酸激酶蛋白受体拮抗剂
|
US8367700B2
(en)
|
2008-12-17 |
2013-02-05 |
Gruenenthal Gmbh |
Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
JP5899607B2
(ja)
|
2009-03-16 |
2016-04-06 |
住友化学株式会社 |
化合物、光学フィルム及び光学フィルムの製造方法
|
KR101641385B1
(ko)
|
2009-03-16 |
2016-07-20 |
스미또모 가가꾸 가부시끼가이샤 |
화합물, 광학 필름 및 광학 필름의 제조 방법
|
TW201100398A
(en)
|
2009-03-31 |
2011-01-01 |
Arqule Inc |
Substituted indolo-pyridinone compounds
|
WO2010151799A2
(en)
|
2009-06-26 |
2010-12-29 |
University Of Massachusetts |
Compounds for modulating rna binding proteins and uses therefor
|
JP5669481B2
(ja)
|
2009-08-21 |
2015-02-12 |
大塚製薬株式会社 |
医薬組成物
|
GB0914767D0
(en)
|
2009-08-24 |
2009-09-30 |
Sterix Ltd |
Compound
|
US20110177105A1
(en)
|
2010-01-15 |
2011-07-21 |
Roman Lopez |
Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications
|
SI2536706T1
(sl)
|
2010-02-11 |
2017-10-30 |
Celgene Corporation |
Derivati arilmetoksi izoindolina in sestavki,ki jih vsebujejo ter metode uporabe le-teh
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
US8697911B2
(en)
|
2010-07-07 |
2014-04-15 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
US9079880B2
(en)
|
2010-07-07 |
2015-07-14 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
SG187742A1
(en)
|
2010-08-20 |
2013-03-28 |
Hutchison Medipharma Ltd |
Pyrrolopyrimidine compounds and uses thereof
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
US20130203756A1
(en)
|
2010-10-29 |
2013-08-08 |
Jamie L. Bunda |
Isoindoline pde10 inhibitors
|
US9173887B2
(en)
|
2010-12-22 |
2015-11-03 |
Abbvie Inc. |
Hepatitis C inhibitors and uses thereof
|
EP3345901A3
(en)
|
2011-06-29 |
2018-09-12 |
President and Fellows of Harvard College |
Small molecules as antiaging agents
|
EP3495470A1
(en)
|
2011-06-29 |
2019-06-12 |
The General Hospital Corporation |
In vivo methods for enhancing bioenergetic status in female germ cells
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
JP2014198669A
(ja)
|
2011-08-03 |
2014-10-23 |
杏林製薬株式会社 |
ビアリールエステル誘導体、及びそれらを有効成分とする医薬
|
AU2012296662A1
(en)
|
2011-08-15 |
2014-03-27 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
ES2647486T3
(es)
|
2011-12-22 |
2017-12-21 |
Gilead Sciences, Inc. |
Pirazolo[1,5-a]pirimidinas como agentes antivirales
|
MX2014007729A
(es)
|
2011-12-23 |
2015-01-12 |
Novartis Ag |
Compuestos para inhibir la interaccion de bcl2 con los componentes de enlace.
|
JP2015503518A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Bcl2と結合相手の相互作用を阻害するための化合物
|
CA2859876A1
(en)
|
2011-12-23 |
2013-06-27 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
CN104136429A
(zh)
|
2011-12-23 |
2014-11-05 |
诺华股份有限公司 |
用于抑制bcl2与结合配偶体相互作用的化合物
|
CZ2012114A3
(cs)
|
2012-02-17 |
2013-02-20 |
Zentiva, K.S. |
Zpusob prípravy rivaroxabanu zalozený na úspore 1,1´ -karbonyldiimidazolu
|
US8859541B2
(en)
|
2012-02-27 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
6-alkynylpyridines
|
AU2013265307B2
(en)
|
2012-05-24 |
2016-04-07 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as TYK2 inhibitors
|
EP2669276A1
(en)
|
2012-05-31 |
2013-12-04 |
Université de Strasbourg |
Ornithine- and lysine-derivatives for the treatment of pain
|
CA2877301A1
(en)
|
2012-06-20 |
2013-12-27 |
Michael J. Heller |
Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems
|
FR2993564B1
(fr)
|
2012-07-20 |
2014-08-22 |
Metabrain Res |
Derives d'imidazopyridine utiles dans le traitement du diabete
|
WO2014015905A1
(en)
|
2012-07-26 |
2014-01-30 |
Glaxo Group Limited |
2 - (azaindol- 2 -yl) benz imidazoles as pad4 inhibitors
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
US9701676B2
(en)
|
2012-08-24 |
2017-07-11 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
EP2921229A1
(en)
|
2012-11-15 |
2015-09-23 |
Takasago International Corporation |
Aluminum catalyst
|
EP2935242A2
(en)
|
2012-12-21 |
2015-10-28 |
Epizyme, Inc. |
Methods of inhibiting prmt5
|
JP6678455B2
(ja)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
EP2968303B1
(en)
|
2013-03-14 |
2018-07-04 |
The Trustees of Columbia University in the City of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
FR3008976A1
(fr)
|
2013-07-23 |
2015-01-30 |
Servier Lab |
"nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
|
MX2016002075A
(es)
|
2013-08-27 |
2016-05-26 |
Squibb Bristol Myers Co |
Inhibidores de indolamina 2,3-dioxigenasa (ido).
|
MX2016002544A
(es)
|
2013-09-04 |
2016-06-17 |
Squibb Bristol Myers Co |
Compuestos utiles como inmunomoduladores.
|
GB201321730D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321746D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2015108038A1
(ja)
|
2014-01-17 |
2015-07-23 |
第一三共株式会社 |
エチレングリコール化合物
|
JP6569661B2
(ja)
|
2014-02-27 |
2019-09-04 |
小野薬品工業株式会社 |
選択的ep2アゴニスト活性を有する化合物
|
US9067898B1
(en)
|
2014-03-07 |
2015-06-30 |
Janssen Pharmaceutica Nv |
Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes
|
CN110183440B
(zh)
|
2014-03-19 |
2022-04-22 |
勃林格殷格翰国际有限公司 |
杂芳基syk抑制剂
|
CN106065009B
(zh)
|
2014-06-28 |
2019-03-01 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的化合物及其在药物中的应用
|
DK3169671T3
(da)
|
2014-07-17 |
2019-09-23 |
Sunshine Lake Pharma Co Ltd |
1-(5-(tert.-butyl)isoxazol-3-yl)-3-(4-((phenyl)ethynyl)phenyl)ureaderivater og relaterede forbindelser som flt3-inhibitorer til behandling af kræft
|
EP3187497A4
(en)
|
2014-08-26 |
2018-02-07 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
GB201415573D0
(en)
|
2014-09-03 |
2014-10-15 |
Cancer Therapeutics Crc Pty Ltd |
Compounds
|
US9877957B2
(en)
|
2014-09-05 |
2018-01-30 |
Merck Sharp & Dohme Corp. |
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
|
CN105461693B
(zh)
|
2014-09-26 |
2019-10-25 |
广东东阳光药业有限公司 |
Crth2拮抗剂化合物及其用途
|
AU2015326506B2
(en)
|
2014-10-03 |
2021-02-25 |
Divya MAHESHWARI |
Novel anthranilic acid derivatives
|
ES2578377B1
(es)
|
2014-12-22 |
2017-05-04 |
Consejo Superior De Investigaciones Científicas (Csic) |
Compuestos moduladores del sensor neuronal de calcio dream y sus usos terapéuticos.
|
JP6703553B2
(ja)
*
|
2015-05-21 |
2020-06-03 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Pad4阻害剤としてのベンゾイミダゾール誘導体
|
EP4129278A1
(en)
|
2015-07-03 |
2023-02-08 |
Lars Klareskog |
Methods and compounds for the alleviation and/or prevention of bone loss and/or pain
|
US10246429B2
(en)
|
2015-08-06 |
2019-04-02 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
US10906897B2
(en)
|
2015-08-12 |
2021-02-02 |
Syngenta Participations Ag |
Microbiocidal heterobicyclic derivatives
|
CN108349996B
(zh)
|
2015-09-08 |
2021-01-08 |
豪夫迈·罗氏有限公司 |
三环pi3k抑制剂化合物及其使用方法
|
CA3001799A1
(en)
|
2015-10-21 |
2017-04-27 |
Otsuka Pharmaceutical Co., Ltd. |
Benzolactam compounds as protein kinase inhibitors
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
EP3394050A1
(en)
|
2015-12-22 |
2018-10-31 |
AbbVie Deutschland GmbH & Co. KG |
Fused (hetero)cyclic compounds as s1p modulators
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
CA3015482A1
(en)
|
2016-02-23 |
2017-08-31 |
Padlock Therapeutics, Inc. |
Heteroaryl inhibitors of pad4
|
WO2017216281A1
(en)
|
2016-06-16 |
2017-12-21 |
Janssen Sciences Ireland Uc |
Heterocyclic compounds as antibacterials
|
WO2018002848A1
(en)
|
2016-06-30 |
2018-01-04 |
VIIV Healthcare UK (No.5) Limited |
Azadecalin derivatives as inhibitors of human immunodeficiency virus replication
|
EP3492462B1
(en)
|
2016-07-26 |
2023-08-30 |
Shenzhen TargetRx, Inc. |
Amino pyrimidine compound for inhibiting protein tyrosine kinase activity
|
JP2019530732A
(ja)
|
2016-08-03 |
2019-10-24 |
アライジング・インターナショナル・インコーポレイテッドArising International, Inc. |
免疫モジュレータとして有用な対称または半対称化合物
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為malt1抑制劑之吡唑衍生物
|
WO2018112843A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
|
CN110099900B
(zh)
|
2016-12-27 |
2022-12-02 |
山东大学 |
针对Smoothened突变株的刺猬通路抑制剂
|
CN107056630B
(zh)
|
2017-01-23 |
2020-01-17 |
合肥工业大学 |
一种茚满类衍生物及其合成方法和在医药上的用途
|
EP3601245A1
(en)
|
2017-03-28 |
2020-02-05 |
The Regents of The University of Michigan |
Small molecule dcn1 inhibitors and therapeutic methods using the same
|
WO2018208985A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
CN107163044B
(zh)
|
2017-06-19 |
2021-04-23 |
广东药科大学 |
一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物
|
JP2020524663A
(ja)
|
2017-06-21 |
2020-08-20 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Irak4調節因子としてのイソインドリノン誘導体
|
GB201710851D0
(en)
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
EP3684767B1
(en)
|
2017-09-22 |
2024-04-24 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
CN111225915B
(zh)
|
2017-10-18 |
2023-03-07 |
朱比兰特埃皮帕德有限公司 |
作为pad抑制剂的咪唑并吡啶化合物
|
IL310346A
(en)
|
2017-10-20 |
2024-03-01 |
Univ Vanderbilt |
Muscarinic acetylcholine M4 receptor antagonists
|
WO2019087214A1
(en)
|
2017-11-06 |
2019-05-09 |
Jubilant Biosys Limited |
Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation
|
CN111542523B
(zh)
|
2017-11-24 |
2024-03-29 |
朱比连特埃皮斯科瑞有限责任公司 |
作为prmt5抑制剂的杂环化合物
|
EP3728221B1
(en)
|
2017-12-19 |
2022-06-01 |
Bristol-Myers Squibb Company |
Amide substituted indole compounds useful as tlr inhibitors
|
CN110117278B
(zh)
|
2018-02-07 |
2022-07-19 |
石家庄以岭药业股份有限公司 |
烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
|
WO2019160014A1
(ja)
|
2018-02-14 |
2019-08-22 |
富士フイルム株式会社 |
重合性液晶組成物、光学異方性膜、光学フィルム、偏光板および画像表示装置
|
AU2019234185A1
(en)
|
2018-03-13 |
2020-10-01 |
Jubilant Prodel LLC. |
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation
|
JP6956033B2
(ja)
|
2018-03-14 |
2021-10-27 |
日本化薬株式会社 |
ベンゾアゾール化合物、並びにこれを含んだ顔料組成物
|
CN108358917B
(zh)
|
2018-04-24 |
2020-06-19 |
北京市结核病胸部肿瘤研究所 |
含有碱性稠环片段的咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法
|
CN112041296B
(zh)
|
2018-04-28 |
2023-12-29 |
上海璃道医药科技有限公司 |
包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
|
WO2019213234A1
(en)
|
2018-05-01 |
2019-11-07 |
The Trustees Of Columbia University In The City Of New York |
Triazolopyrimidines, their preparation and use
|
EP3829575A4
(en)
|
2018-08-01 |
2022-07-20 |
The Trustees of Columbia University in the City of New York |
RBP4 ANTAGONISTS FOR THE TREATMENT AND PREVENTION OF NON-ALCOHOLIC LIVER DISEASE AND GOUT
|
CA3107548A1
(en)
|
2018-08-06 |
2020-02-13 |
Moexa Pharmaceuticals Limited |
Smad3 inhibitors
|
CN112654903B
(zh)
|
2018-08-28 |
2022-09-27 |
富士胶片株式会社 |
层叠体及图像显示装置
|
CN110963997A
(zh)
|
2018-09-28 |
2020-04-07 |
四川科伦博泰生物医药股份有限公司 |
杂环酰胺类化合物、包含其的药物组合物及其制备方法和用途
|
EP3643711A1
(en)
|
2018-10-24 |
2020-04-29 |
Bayer Animal Health GmbH |
New anthelmintic compounds
|
KR102641718B1
(ko)
|
2018-10-30 |
2024-02-29 |
길리애드 사이언시즈, 인코포레이티드 |
알파4베타7 인테그린 억제제로서의 이미다조피리딘 유도체
|
CN110105299B
(zh)
|
2019-01-23 |
2023-01-03 |
中山大学 |
一种含芳醚取代恶唑烷酮羧酸酯类衍生物及其制备方法和应用
|
WO2020201773A1
(en)
|
2019-04-05 |
2020-10-08 |
Storm Therapeutics Ltd |
Mettl3 inhibitory compounds
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
JP7420502B2
(ja)
|
2019-07-24 |
2024-01-23 |
住友化学株式会社 |
重合性液晶混合組成物、位相差板、楕円偏光板および有機el表示装置
|
AR119494A1
(es)
|
2019-07-29 |
2021-12-22 |
Servier Lab |
DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS
|
WO2021028810A1
(en)
|
2019-08-09 |
2021-02-18 |
Inorbit Therapeutics Ab |
Sulfinic acid compounds as free fatty acid receptor agonists
|
WO2021060432A1
(ja)
|
2019-09-27 |
2021-04-01 |
富士フイルム株式会社 |
液晶組成物、光学異方性層、光学フィルム、偏光板および画像表示装置
|
JP7182533B2
(ja)
|
2019-09-27 |
2022-12-02 |
富士フイルム株式会社 |
液晶組成物、光学異方性層、光学フィルム、偏光板および画像表示装置
|
MX2022005679A
(es)
|
2019-11-15 |
2022-06-27 |
Yuhan Corp |
Nuevos derivados que tienen una fraccion de 2,3-dihidro-1h-indeno o 2,3-dihidrobenzofurano o una sal farmaceuticamente aceptable de los mismos y composiciones farmaceuticas que los comprenden.
|
WO2021095241A1
(ja)
|
2019-11-15 |
2021-05-20 |
三菱電機株式会社 |
エッジ機器連携システム、エッジ機器連携方法及びプログラム
|
CN111606904B
(zh)
|
2020-04-07 |
2021-10-15 |
广州医科大学 |
氮杂吲哚类化合物及其应用
|